These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30535628)

  • 1. Advance for Cardiovascular Health in China.
    Bei Y; Shi C; Zhang Z; Xiao J
    J Cardiovasc Transl Res; 2019 Jun; 12(3):165-170. PubMed ID: 30535628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular medicine in China: what can we do to achieve the Healthy China 2030 plan?
    Bei Y; Yang T; Xiao J
    BMC Med; 2018 Aug; 16(1):132. PubMed ID: 30139358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology for Diagnosis, Treatment, and Prevention of Cardiometabolic Disease in India.
    Hameed SS; Rawal I; Soni D; Ajay VS; Goenka S; Prabhakaran D
    Prog Cardiovasc Dis; 2016; 58(6):620-9. PubMed ID: 26943979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of m-Health Technology for Preventive Interventions to Tackle Cardiometabolic Conditions and Other Non-Communicable Diseases in Latin America- Challenges and Opportunities.
    Beratarrechea A; Diez-Canseco F; Irazola V; Miranda J; Ramirez-Zea M; Rubinstein A
    Prog Cardiovasc Dis; 2016; 58(6):661-73. PubMed ID: 27041078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let's Face It: Consumer-Focused Technology Is the Future of Cardiovascular Disease Prevention and Treatment.
    Franklin NC; Pratt M
    Prog Cardiovasc Dis; 2016; 58(6):577-8. PubMed ID: 27180944
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical organisation of preventive cardiology programmes: integrating prevention and rehabilitation.
    Saner H; Wood D
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S37-42. PubMed ID: 19675435
    [No Abstract]   [Full Text] [Related]  

  • 7. 2020: A Crash Course in Digital Health.
    Soliman AM; Zoghbi WA
    Methodist Debakey Cardiovasc J; 2020; 16(4):261-262. PubMed ID: 33500753
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in the prevention and treatment of cardiovascular disease.
    Weisfeldt ML; Zieman SJ
    Health Aff (Millwood); 2007; 26(1):25-37. PubMed ID: 17211011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for cardiovascular rehabilitation and secondary prevention in China 2018 simplified edition].
    Commitee of Cardiac Rehabilitation and Prevention of Chinese Association of Rehabilitation Medicine
    Zhonghua Nei Ke Za Zhi; 2018 Nov; 57(11):802-810. PubMed ID: 30392235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multidisciplinary approach to prevention.
    Jennings C; Astin F
    Eur J Prev Cardiol; 2017 Jun; 24(3_suppl):77-87. PubMed ID: 28618913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eHealth in cardiovascular medicine: A clinical update.
    Saner H; van der Velde E
    Eur J Prev Cardiol; 2016 Oct; 23(2 suppl):5-12. PubMed ID: 27892420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive Cardiology Update: Controversy, Consensus, and Future Promise.
    Berry JD
    Prog Cardiovasc Dis; 2015; 58(1):1-2. PubMed ID: 25968931
    [No Abstract]   [Full Text] [Related]  

  • 13. Do clinicians prescribe exercise similarly in patients with different cardiovascular diseases? Findings from the EAPC EXPERT working group survey.
    Hansen D; Rovelo Ruiz G; Doherty P; Iliou MC; Vromen T; Hinton S; Frederix I; Wilhelm M; Schmid JP; Abreu A; Ambrosetti M; Garcia-Porrero E; Coninx K; Dendale P;
    Eur J Prev Cardiol; 2018 May; 25(7):682-691. PubMed ID: 29486587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the use of bromelain in cardiovascular diseases.
    Ley CM; Tsiami A; Ni Q; Robinson N
    Zhong Xi Yi Jie He Xue Bao; 2011 Jul; 9(7):702-10. PubMed ID: 21749819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 10-year anniversary of the European Association for Cardiovascular Prevention and Rehabilitation: achievements and challenges.
    Perk J; DeBacker G; Saner H; Wood D; Giannuzzi P; Gielen S; Pelloiccia A
    Eur J Prev Cardiol; 2015 Oct; 22(10):1340-5. PubMed ID: 25208907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The development and codesign of the PATHway intervention: a theory-driven eHealth platform for the self-management of cardiovascular disease.
    Walsh DMJ; Moran K; Cornelissen V; Buys R; Claes J; Zampognaro P; Melillo F; Maglaveras N; Chouvarda I; Triantafyllidis A; Filos D; Woods CB
    Transl Behav Med; 2019 Jan; 9(1):76-98. PubMed ID: 29554380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wild Wild West: A Framework to Integrate mHealth Software Applications and Wearables to Support Physical Activity Assessment, Counseling and Interventions for Cardiovascular Disease Risk Reduction.
    Lobelo F; Kelli HM; Tejedor SC; Pratt M; McConnell MV; Martin SS; Welk GJ
    Prog Cardiovasc Dis; 2016; 58(6):584-94. PubMed ID: 26923067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifestyle modification interventions and cardiovascular health: global perspectives on worksite health and wellness and cardiac rehabilitation.
    Arena R
    Prog Cardiovasc Dis; 2014; 56(5):473-5. PubMed ID: 24607010
    [No Abstract]   [Full Text] [Related]  

  • 19. Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention.
    Kones R
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):61-81. PubMed ID: 21183531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemic of Cardiovascular Disease in China: Current Perspective and Prospects for the Future.
    Shen C; Ge J
    Circulation; 2018 Jul; 138(4):342-344. PubMed ID: 30571361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.